NEWS
- Antibody-drug Conjugates for HER2-Positive Gastric Cancer
- c-MET: A Novel Target for Anticancer Therapies
- Nectin-4-Directed Drugs for Solid Tumors
- Claudin18.2 Targeted Therapies In Cancer
- FDA Approves Tivdak - First Tissue Factor (TF)-Targeted Antibody Conjugate Drug (ADC)
- ADC Drugs Global Sales of 2021 and Future Prospects
- Global Sales of ADCs in 2022 – UP to 7 Billion
- FDA Accelerated Approval of ELAHERE™ (mirvetuximab soravtansine-gynx)
- EGFR-Directed ADCs for Cancer Treatment
- Kadcyla - Top-Selling Antibody Drug Conjugate (ADC)